Apixaban

Trade Name: 
Eliquis
Manufacturer/Distributor: 
Bristol-Myers Squibb / Pfizer
www.bmscanada.ca
Classification: 
Anticoagulant
ATC Class: 
B01AF02 - apixaban
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/12/16
Date Marketed in Canada (yyyy/mm/dd): 
2012/03
Presentation: 
Tablet: 2.5 mg. DIN: 02377233
Comments: 
Only approved for prevention of venous thromboembolic events in adults who have undergone elective knee or hip surgery. This is a direct factor Xa inhibitor that does not require routine anticoagulant monitoring.
Browse by keywords: